SEC Filings

SEC Filings

Filing date Description Form Filing Group Issuer View

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Clementia Pharmaceuticals Inc. View HTML

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

424B5
Registration Statements
Clementia Pharmaceuticals Inc. View HTML

EFFECT

EFFECT
Other
Clementia Pharmaceuticals Inc. View HTML

Registration statement for certain foreign private issuers offered for certain transactions

F-3
Registration Statements
Clementia Pharmaceuticals Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Clementia Pharmaceuticals Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Clementia Pharmaceuticals Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Clementia Pharmaceuticals Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Clementia Pharmaceuticals Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Clementia Pharmaceuticals Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Clementia Pharmaceuticals Inc. EX-101.INS - XBRL INSTANCE FILE View HTML

Copyright Morningstar